^
over3years
New P1 trial
|
CLDN18 (Claudin 18)
|
LY011
over3years
Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer (clinicaltrials.gov)
P1, N=30, Recruiting, Shanghai Longyao Biotechnology Inc., Ltd.
Clinical • New P1 trial • CAR T-Cell Therapy
|
CLDN18 (Claudin 18)
|
LY011